Projected Long-Term Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hepatitis C Outcomes in the United States: A Modeling StudyJoshua A. Barocas, Laura F. White, Alexandra Savinkina et al.|Clinical Infectious Diseases|2021Cited by 26
Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co‐infectionSara Lodi, Miguel A. Hernán, M. John Gill et al.|Journal of the International AIDS Society|2022Cited by 14
Time to direct-acting antiviral initiation and liver-related events in people with HIV and hepatitis C virusMathieu Chalouni, Sara Lodi, Daniela K van Santen et al.|AIDS|2025Cited by 2
Risk of Hepatocellular Carcinoma After Direct-Acting Antiviral Treatment for Hepatitis C Virus Infection in People With HIVDaniela K van Santen, Sara Lodi, Mathieu Chalouni et al.|Clinical Infectious Diseases|2025Cited by 0
Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for hepatitis C virus in people with HIVMathieu Chalouni, Sara Lodi, Jessie Torgersen et al.|AIDS|2026Cited by 0